This discovery is a unique technique for treating memory and mood disorders. The method is comprised of the administration of a compound that inhibits the protein-protein interaction. These compounds can be used to treat or prevent disorders associated with increased alpha 5 GABA-A receptor function such as memory and mood disorders associated with inflammation or after general anaesthesia.
Ian Stewart
Ian Stewart
Innovations & Entrepreneurship Manager
Innovations & Partnerships Office (IPO)
(416) 946-7734